SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Black Diamond Therapeutics shares are trading higher after the company was granted Fast Track designation by the FDA for BDTX-189 for treatment of adult patients with a solid tumor harboring an allosteric HER2 mutation or an EGFR or HER2 Exon 20 Insertion UPDATE: Shares have since reversed, now lower.

Benzinga · -